Nomura Downgrades Cummins India to Neutral Despite 25 Target Price Hike on Valuation Concerns MBX Q1 2026 Earnings EPS Beat Narrows Loss Amid PreRevenue Phase Innovent Biologics and Pfizer Sign Drug Deal Valued at Up to 105 Billion